SPTX
Seaport Therapeutics, Inc. Common StockNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$927.99M
P/E Ratio
—
EPS
$-1.94
Beta
—
52W High
$23.00
52W Low
$0.01
50-Day MA
$16.48
200-Day MA
$16.48
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Seaport Therapeutics, Inc. Common Stock
Seaport Therapeutics, Inc. (SPTX) is an innovative biopharmaceutical company focused on developing transformative therapies for unmet medical needs in the field of immune-oncology. Leveraging cutting-edge technology and a robust research pipeline, Seaport aims to enhance treatment options that target complex diseases, particularly in cancer. The company's commitment to advancing scientific discovery is reflected in its strategic partnerships and collaborations, which bolster its position in the rapidly evolving therapeutics landscape. With a dedicated management team and a visionary approach, Seaport Therapeutics is well-positioned to make significant contributions to patient care and overall clinical outcomes.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-85.22M |
| Operating Margin | 0.00% |
| Return on Equity | -28.10% |
| Return on Assets | -18.90% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-11.35 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $53.03M |
| Float | $2.89M |
| % Insiders | 35.39% |
| % Institutions | 28.64% |
More HEALTHCARE Stocks
Data last updated: 5/25/2026